214
Views
74
CrossRef citations to date
0
Altmetric
Review

Diagnosis of pulmonary tuberculosis in children: new advances

, &
Pages 277-288 | Published online: 10 Jan 2014

References

  • Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Beyers N. The burden of childhood tuberculosis and the accuracy of community based surveillance data. Int. J. Tubercl. Lung Dis.10, 259–263 (2006).
  • Zar HJ, Hanslo D, Tannenbaum E et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr.90(2), 119–125 (2001).
  • Madhi SA, Petersen K, Madhi A, Khoosal M, Klugman KP. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency type 1-infected children. Clin. Infect. Dis.31, 170–176 (2000).
  • McNally LM, Jeena PM, Gajee K et al. Effect of age, polymicrobial disease and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet369, 1440–1451 (2007).
  • Chintu C, Mudenda V, Lucas S et al.; UNZA-UCLMS Project Paediatric Post-mortem Study Group. Lung disease at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet360, 985–990 (2002).
  • Gray D, Zar HJ. Management of community-acquired pneumonia in HIV-infected children. Expert Rev. Anti Infect. Ther.7(4), 437–451 (2009).
  • Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med.163(9), 1009–1021 (2003).
  • Lawn SD, Bekker L-G, Middelkop K, Wood R. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age specific interventions. Clin. Infect. Dis.42, 1040–1047 (2006).
  • Braitstein P, Nyandiko W, Vreeman R et al. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in western Kenya and the impact of combination antiretroviral treatment. Pediatr. Infect. Dis. J.28(7), 626–632 (2009).
  • Walters E, Cotton MF, Rabie H, Schaaf HS, Walters LO, Marais BJ. Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr.8, 1 (2008).
  • Zar HJ, Cotton MF, Strauss S et al. Effect of isoniazid prophylaxis on mortality and incidence of TB in children with HIV – randomised controlled trial. Br. Med. J.334(7585), 136–139 (2007).
  • Hesseling AC, Cotton MF, Jennings T et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin. Infect. Dis.48(1), 108–114 (2009).
  • Marais BJ, Graham SM, Cotton MF, Beyers N. Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J. Infect. Dis.196(Suppl. 1), S76–S85 (2007).
  • Palme IB, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr. Infect. Dis. J.21(11), 1053–1061 (2002).
  • Mukadi YD, Wiktor SZ, Coulibaly IM et al. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Cote d’Ivoire. AIDS11(9), 1151–1158 (1997).
  • Zampoli M, Kilborn T, Eley B. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children. Int. J. Tuberc. Lung Dis.11, 417–423 (2007).
  • Hesseling AC, Schaaf HS, Gie RP, Starke JR, Beyers N. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int. J. Tuberc. Lung Dis.6(12), 1038–1045. (2002).
  • Van Rheenen P. The use of the paediatric tuberculosis score chart in an HIV-endemic area. Trop. Med. Int. Health7(5), 435–441 (2002).
  • Pedrozo C, Sant’Anna C, de Fátima March M, Lucena S. Clinical scoring system for paediatric tuberculosis in HIV-infected and non-infected children in Rio de Janeiro. Int. J. Tuberc. Lung Dis.13(3), 413–415 (2009).
  • Marais BJ, Gie RP, Schaaf HS et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatwrics118, e1350–e1359 (2006).
  • Gie R. Diagnostic Atlas of Intrathoracic Tuberculosis in Children: a Guide for Low Income Countries. International Union against Tuberculosis and Lung Disease. Paris, France (2003).
  • Swingler GH, Du Toit G, Van der Merwe L, Andronikou S, Zar HJ. Diagnostic accuracy of chest radiography in detecting mediastinal lymphadenopathy in suspected pulmonary tuberculosis. Arch. Dis. Child90, 1153–1156 (2005).
  • WHO. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. WHO/HTM/TB/2006.371. WHO, Geneva, Switzerland (2006).
  • Zar HJ, Tannenbaum E, Apolles P, Roux P, Hanslo D, Hussey G. Sputum induction for the diagnosis of pulmonary tuberculosis in infants and young children in an urban setting in South Africa. Arch. Dis. Child82, 305–308 (2000).
  • Zar HJ, Hanslo D, Apolles P, Swingler G, Hussey G. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet365, 130–134 (2005).
  • Uriyo J, Gosling RD, Maddox V et al. Prevalences of Pneumocystis jiroveci, Mycobacterium tuberculosis and Streptococcus pneumoniae infection in children with severe pneumonia, in a tertiary referral hospital in northern Tanzania. Ann. Trop. Med. Parasitol.100(3), 245–249 (2006).
  • Iriso R, Mudido PM, Karamagi C, Whalen C. The diagnosis of childhood tuberculosis in an HIV-endemic setting and the use of induced sputum. Int. J. Tuberc. Lung Dis.9(7), 716–726 (2005).
  • Singh M, Mynak ML, Kumar L, Mathew JL, Jindal SK. Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch. Dis. Child.90(6), 624–628 (2005).
  • Hatherhill M, Hawkridge A, Zar HJ et al. Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis? Arch. Dis. Child94(3), 195–201 (2009).
  • Owens S, Abdel-Rahman IE, Balyejusa S et al. Nasopharyngeal aspiration for diagnosis of pulmonary tuberculosis. Arch. Dis. Child92, 693–696 (2007).
  • Chow F, Espiritu N, Gilman RH et al. La cuerda dulce – a tolerability and acceptability study of a novel approach to specimen collection for diagnosis of paediatric pulmonary tuberculosis. BMC Infect. Dis.6, 67 (2000).
  • Wright CA, van der Burg M, Geiger D, Noordzij JG, Burgess SM, Marais BJ. Diagnosing mycobacterial lymphadenitis in children using fine needle aspiration biopsy: cytomorphology, ZN staining and autofluorescence – making more of less. Diagn. Cytopathol.36(4), 245–251 (2008).
  • Steingart KR, Henry M, Ng V et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis.6, 570–581 (2006).
  • Marais BJ, Brittle W, Painczyk K et al. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin. Infect. Dis.47(2), 203–207 (2008).
  • Marais BJ, Pai M. Recent advances in the diagnosis of childhood tuberculosis. Arch. Dis. Child92(5), 446–452 (2007).
  • Drobniewski FA, Caws M, Gibson A, Young D. Modern laboratory diagnosis of tuberculosis. Lancet Infect. Dis.3, 141–147 (2003).
  • Moore DAJ, Evans CAW, Gilman RH et al. Microscopic-observation drug-susceptibility – assay for the diagnosis of TB. N. Engl. J. Med.355, 1539–1155 (2006).
  • Oberhelman RA, Soto-Castellares G, Caviedes L et al. Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method. Pediatrics118(1), e100–e106 (2006).
  • Flores E, Rodríguez JC, Garcia-Pachón E et al. Real-time PCR with internal amplification control for detecting tuberculosis: method design and validation. APMIS17(8), 592–597 (2009).
  • Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS ONE3(2), e1536 (2008).
  • Guerra RL, Hooper NM, Baker JF et al. Use of the amplified Mycobacterium tuberculosis direct test in a public health laboratory: test performance and impact on clinical care. Chest132(3), 946–951 (2007).
  • Flores LL, Pai M, Colford JM Jr, Riley LW. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression. BMC Microbiol.5, 55 (2005).
  • Delacourt C, Poveda JD, Chureau C et al. Use of polymerase chain reaction for improved diagnosis of tuberculosis in children. J. Pediatr.126(5 Pt 1), 703–709 (1995).
  • Smith KC, Starke JR, Eisenach K, Ong LT, Denby M. Detection of Mycobacterium tuberculosis in clinical specimens from children using a polymerase chain reaction. Pediatrics97(2), 155–160 (1996).
  • Fauville-Dufaux M, Waelbroeck A, De Mol P et al. Contribution of the polymerase chain reaction to the diagnosis of tuberculous infections in children. Eur. J. Pediatr.155(2), 106–111 (1996).
  • Gomez-Pastrana D, Torronteras R, Caro P et al. Diagnosis of tuberculosis in children using a polymerase chain reaction. Pediatr. Pulmonol.28(5), 344–351 (1999).
  • Gomez-Pastrana D, Torronteras R, Caro P et al. Comparison of amplicor, in-house polymerase chain reaction, and conventional culture for the diagnosis of tuberculosis in children. Clin. Infect. Dis.32(1), 17–22 (2001).
  • Montenegro SH, Gilman RH, Sheen P et al. Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin. Infect. Dis.36(1), 16–23 (2003).
  • Gomez-Pastrana D. Tuberculosis in children – is PCR the diagnostic solution. Clin. Microbiol. Infect.8, 541–544 (2002).
  • Davis JL, Huang L, Kovacs JA et al. Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin. Infect. Dis.48, 725–732. (2009).
  • Boehme CC, Molokova E, Minja F et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans. R. Soc. Trop. Med. Hyg.99, 893–900 (2005).
  • Daley P, Michael JS, Hmar P et al. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int. J. Tuberc. Lung Dis.13(8), 989–995 (2009).
  • Mutetwa R, Boehme C, Dimairo M et al. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int. J. Tuberc. Lung Dis.13(10), 1253–1259 (2009).
  • Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am. J. Epidemiol.99(2), 131–138 (1974).
  • Enarson DA. Use of the tuberculin skin test in children. Paediatr. Respir. Rev.5(Suppl. A), S135–S137 (2004).
  • Menzies D. The tuberculin skin test. In: Tuberculosis, a Comprehensive International Approach. Reichman L, Hershfield E (Eds). Marcel Dekker, NY, USA, 279–322 (2000).
  • Andersen P, Munk ME, Pollack JM, Doherty MT. Specific immune-based diagnosis of tuberculosis. Lancet356, 1099–1104 (2000).
  • Connell TG, Rangaka MX, Curtis N, Wilkinson RJ. QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection? Expert Rev. Mol. Diagn.6(5), 663–677 (2006).
  • Lalvani A, Pareek M. Interferon g release assays: principles and practice. Enfermedades Infecciosas y Microbiologia Clinica (2009) (Epub ahead of print).
  • Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med.146(5), 340–354 (2007).
  • Canadian Tuberculosis Committee. Interferon γ release assays for latent tuberculosis infection. In: Canada Communicable Disease Report. Canadian Tuberculosis Committee, Canada, 33 (2007).
  • Davies MA, Connell T, Johannisen C et al. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS23(8), 961–969 (2009).
  • Dogra S, Narang P, Mendiratta DK et al. Comparison of a whole blood interferon-γ assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J. Infect.54, 3, 267–276 (2006).
  • Hill PC, Brookes RH, Adetifa IMO et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Myocbacterium tuberculosis. Pediatrics117, 1542–1548 (2006).
  • Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet364(9452), 2196–2203 (2004).
  • Nakaoka H, Lawson L, Bertel Squire S et al. Risk for tuberculosis among children. Emerg. Infect. Dis.12(9), 1383–1388 (2006).
  • Nicol MP, Davies MA, Wood K et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics123(1), 38–43 (2009).
  • Bakir M, Millington KA, Soysal A et al. Prognostic value of a T-cell-based, interferon-γ biomarker in children with tuberculosis contact. Ann. Intern. Med.149, 777–787 (2008).
  • Bamford AR, Angela CM, Clark J et al. Comparison of interferon-γ release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK – a paediatric TB network study. Arch. Dis. Child. DOI:10.1136/adc.2009.169805 (2009) (Epub ahead of print).
  • Bergamini BM, Losi M, Vaienti F et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics123(3), e419–e424 (2009).
  • Bianchi L, Galli L, Moriondo M et al. Interferon-γ release assay improves the diagnosis of tuberculosis in children. Pediatr. Infect. Dis. J.28, 510–514 (2009).
  • Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon γ assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax61(7), 616–620 (2006).
  • Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PLoS ONE3(7), e2624 (2008).
  • Kampmann B, Whittaker E, Williams A et al. Interferon-γ release assays do not identify more children with active TB than TST. Eur. Respir. J.33(6) 1374–1382 (2009).
  • Soysal A, Millington KA, Bakir M et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet366(9495), 1443–1451 (2005).
  • Okada K, Mao TE, Mori T et al. Performance of an interferon-γ release assay for diagnosing latent tuberculosis infection in children. Epidemiol. Infect.136(9), 1179–1187 (2007).
  • Tavast E, Salo E, Seppala I, Tuuminen T. IGRA tests perform similarly to TST but cause no adverse reactions: pediatric experience in Finland. BMC Res. Notes2(1), 9 (2009).
  • Chun JK, Kim CK, Kim HS et al. The role of a whole blood interferon-γ assay for the detection of latent tuberculosis infection in Bacille Calmette-Guerin vaccinated children. Diagn. Microbiol. Infect. Dis.62(4), 389–394 (2008).
  • Dominguez J, Ruiz-Manzano J, De Souza-Galvao M et al. Comparison of two commercially available interferon-γ blood tests for immunodiagnosis of tuberculosis infection. Clin. Vaccine Immunol.15(1), 168–171 (2007).
  • Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics123(1), 30–37 (2009).
  • Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet361(9364), 1168–1173 (2003).
  • Hesseling AC, Mandalakas AM, Kirchner LH et al. Highly discordant T-Cell responses in individuals with recent household tuberculosis exposure. Thorax64(10), 840–846 (2008).
  • Detjen AK, Keil T, Roll S et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin. Infect. Dis.45(3), 322–328 (2007).
  • Whittaker E, Gordon A, Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNγ? PLoS ONE3(12), e3901 (2008).
  • Haustein T, Ridout DA, Hartley JC et al. The likelihood of an indeterminate test result from a whole-blood interferon-γ release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr. Infect. Dis. J.28(8), 669–673 (2009).
  • Spyridis N, Chakraborty R, Sharland M, Heath PT. Early diagnosis of tuberculosis using an INF-γ assay in a child with HIV-1 infection and a very low CD4 count. Scand. J. Infect. Dis.39(10), 919–921 (2007).
  • Steinfort DP, Johnson DF, Connell TG, Irving LB. Endobronchial ultrasound-guided biopsy in the evaluation of intrathoracic lymphadenopathy in suspected tuberculosis: a minimally invasive technique with a high diagnostic yield. J. Infect.58(4), 309–311 (2009).
  • Barth RE, Mudrikova T, Hoepelman AI. Interferon-γ release assays (IGRAs) in high-endemic settings: could they play a role in optimizing global TB diagnostics? Evaluating the possibilities of using IGRAs to diagnose active TB in a rural African setting. Int. J. Infect. Dis.12(6), e1–e6 (2008).
  • Hill PC, Jackson-Sillah DJ, Fox A et al. Incidence of tuberculosis and the predictive value of ELISPOT and mantoux tests in Gambian case contacts. PLoS ONE3(1), e1379 (2008).
  • Powell DA. Interferon g release assays in the evaluation of children with possible Mycobacterium tuberculosis infection: a view to caution. Pediatr. Infect. Dis. J.28(8), 676–677 (2009).
  • Steingart KR, Henry M, Laal S et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med.4, e202 (2007).
  • Kumar G, Dagur PK, Singh M et al. Diagnostic potential of Ag85C in comparison to various secretory antigens for childhood tuberculosis. Scand. J. Immunol.68(2), 177–183 (2008).
  • WHO. WHO Special Programme for Research & Training in Tropical Diseases Laboratory-Based Evaluation of 19 Commercially Available Rapid Diagnostic Tests for Tuberculosis. Diagnostics Evaluation Series 2. WHO, Geneva, Switzerland (2008).
  • WHO. A Research Agenda for Childhood TB: Improving the Management of Childhood Tuberculosis within National Tuberculosis Programmes: Research Priorities Based on a Literature Review. WHO, Geneva, Switzerland (2007).

Website

  • Health Protection Agency Tuberculosis Programme Board UK. Health Protection Agency Position Statement on the use of interferon-g release assay (IGRA) tests for tuberculosis: draft statement (2007). www.hpa.org.uk

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.